Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
- Worldwide Sales of Cialis Top $233 Million - - Net Income Grows to $75.8 Million for 2006 Second Quarter - BOTHELL, Wash., and INDIANAPOLIS, Ind., July 21 /PRNewswire-FirstCall/ -- Lilly ICOS...
New Survey Reveals State of Emotional and Physical Intimacy of Boomer Relationships BOTHELL, Wash. and INDIANAPOLIS, June 22 /PRNewswire-FirstCall/ -- Compared to all the attention paid to how...
- Cialis Attains Leading ED Market Share Position in Eleven Countries - BOTHELL, Wash. and INDIANAPOLIS, Ind., April 20 /PRNewswire-FirstCall/ -- Lilly ICOS LLC (Lilly ICOS...
- 2005 Fourth Quarter Net Income Surges to $61.4 Million - - 2005 Worldwide Sales Grow 35% - - Company Provides Update on Clinical Plan for BPH - BOTHELL, Wash. and INDIANAPOLIS, Ind., Jan. 20...
BOTHELL, Wash. and INDIANAPOLIS, Ind., Oct. 20 /PRNewswire-FirstCall/ -- Lilly ICOS LLC (Lilly ICOS) (NYSE:LLYNYSE:andNYSE:Nasdaq:NYSE:ICOS) is releasing its financial results for the third...
-- National Survey Shows Misconceptions Still Prevalent: Nearly One in Three Believe Tight Underwear Can Lead to Erectile Dysfunction NEW YORK, Sept. 20 /PRNewswire-FirstCall/ -- According to a...
Lilly ICOS LLC Reports Results for Second Quarter of 2005 - Quarterly net loss narrows to $1.7 million - - Worldwide sales of Cialis(R), since launch, exceed $1 billion - BOTHELL, Wash. and...
Lilly ICOS Tees Up Plans to Bring Second Year Title Sponsorship of Cialis(R) Western Open to New Level -- Luke Donald Artwork, Original Vignettes, The Golf Channel Partnership, Evans Scholars...
Clinical Data Shows Lilly ICOS' Cialis(R) (tadalafil) Improves Erectile Function in ED Patients with Significant, Multiple Comorbid Conditions SAN ANTONIO, Texas, May 23 /PRNewswire-FirstCall/...
Cialis(R) (tadalafil) Overtakes Viagra to Become Number One Selling Erectile Dysfunction Treatment in France - Cialis Achieves 49% of Total Tablet Sales Two Years After its Successful Launch...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.88 | -6.12813370474 | 14.36 | 14.58 | 13.26 | 69594 | 13.86776265 | DE |
| 4 | -1.72 | -11.3157894737 | 15.2 | 15.7 | 13.26 | 70806 | 14.5645187 | DE |
| 12 | -2.22 | -14.1401273885 | 15.7 | 16.58 | 13.26 | 107099 | 15.00706486 | DE |
| 26 | -1.54 | -10.2529960053 | 15.02 | 16.92 | 13.26 | 89279 | 15.40467546 | DE |
| 52 | -0.62 | -4.39716312057 | 14.1 | 16.92 | 12.76 | 79501 | 14.88614969 | DE |
| 156 | -1.92 | -12.4675324675 | 15.4 | 16.92 | 9.755 | 59242 | 14.15809685 | DE |
| 260 | -0.52 | -3.71428571429 | 14 | 17.1 | 9.755 | 65877 | 14.25258989 | DE |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
